Solana-Focused Upexi Files to Raise $1B as Shares Tumble 50%

(UPXI), a Nasdaq-listed firm with one of the largest corporate treasuries of Solana (SOL), has filed to raise up to in capital. The move comes as the company's stock has lost over of its value this year, raising questions about its financial strategy amid a challenging crypto market.

Securing Flexibility Amid Market Headwinds

The company filed a shelf registration with the U.S. Securities and Exchange Commission (), a move that doesn't trigger an immediate sale of securities. Instead, it gives the flexibility to offer and sell securities like common stock, debt instruments, or warrants over time when market conditions are favorable.

Based in Tampa, Florida, manages a portfolio of consumer brands, including Cure Mushrooms and Lucky Tail pet care. However, a significant portion of its balance sheet is tied to its crypto holdings. The company holds over , valued at approximately , making it the fourth-largest treasury of any public company.

A Hedge Against Volatility?

The timing is critical. 's shares (UPXI) are down about year-to-date, while its key digital asset, , has fallen by in the same period. According to the filing, proceeds could be used for general purposes such as working capital, research and development, and debt repayment. This suggests the capital raise may be a strategic move to shore up its finances and reduce its reliance on volatile crypto assets for liquidity.